Universal Health Services, Inc. (UHS) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary provides mixed signals. While there are positive aspects such as revenue growth and operational improvements, there are also concerns about adverse impacts from health insurance exchanges, staffing regulations, and the expected operating loss for a new hospital. The Q&A session highlights uncertainties in Medicaid payments and payer mix changes, but also notes positive trends in behavioral health demand and outpatient growth. Overall, the balance of positive and negative factors suggests a neutral stock price movement over the next two weeks.
Key Financial Performance
Revenue Growth 9.6% increase year-over-year. Reasons for change include steady operating performance, cash flow generation, and efficiency initiatives driven by technology adoption and operational excellence.
Adjusted EBITDA Net of NCI 8.4% increase year-over-year. Reasons for change include solid expense management and higher contributions from pricing in both segments.
Adjusted EPS 16.1% increase year-over-year. Reasons for change include financial discipline and efficiency initiatives.
Net Income Per Diluted Share $5.65 for Q1 2026. Adjusted EPS was $5.62.
Same-Facility Acute Care Net Revenues 8.2% increase year-over-year. Excluding the impact of the health plan, the increase was 6.2%. Reasons for change include positive trends in rate and solid expense management.
Same-Facility Acute Care Revenue Per Adjusted Admission 6.3% increase year-over-year. Excluding prior period supplemental program net benefit, the increase was 4.9%.
Same-Facility Acute Care Salaries, Wages, and Benefits Expense Per Adjusted Admission 3.1% increase year-over-year.
Same-Facility Acute Care Supply Expense Per Adjusted Admission 3.5% increase year-over-year.
Same-Facility Acute Care Segment EBITDA 11.7% growth year-over-year. Excluding prior period supplemental program revenue, the increase was 3.3%.
Health Insurance Exchange Trends Impact Approximately $15 million impact in Q1 2026. Exchange adjusted admissions declined approximately 5% year-over-year.
Same-Facility Behavioral Health Net Revenues 7.3% increase year-over-year. Reasons for change include a 5.8% increase in revenue per adjusted patient day and a 1.6% increase in adjusted patient days.
Same-Facility Behavioral Health Segment EBITDA 8.4% increase year-over-year. Excluding prior period supplemental payments, the increase was 4.3%.
Same-Facility Behavioral Health Salaries, Wages, and Benefits Per Adjusted Patient Day 6% increase year-over-year.
Cash Generated from Operating Activities $402 million for Q1 2026, compared to $360 million in Q1 2025.
Capital Expenditures $217 million spent in Q1 2026.
Share Repurchase 675,000 shares acquired at a total cost of $127 million in Q1 2026.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Talkspace Acquisition: UHS announced the acquisition of Talkspace, a virtual outpatient behavioral health care platform with 6,000 licensed professionals serving all 50 states. This acquisition aims to create an end-to-end continuum of behavioral health care services, including virtual intensive outpatient programs. The deal is expected to be accretive to earnings within the first 12 months post-closing.
Behavioral Health Expansion: UHS is expanding its behavioral health services with the acquisition of Talkspace and the development of new freestanding outpatient clinic locations. This aligns with the strategy to diversify the behavioral payer mix and increase access to outpatient services.
Acute Care Expansion: UHS is investing in new facilities, including a 156-bed hospital in Florida and a 120-bed hospital in Missouri, as well as expanding existing facilities with additional bed towers.
Efficiency Initiatives: UHS implemented AI solutions in revenue cycle operations, yielding significant benefits. In 2026, the focus is on clinical operations to improve hospital efficiency and patient experience, with new use cases being developed with Hippocratic AI.
Expense Management: Operating expenses were well managed, with labor and supply costs increasing moderately. Contract labor costs decreased year-over-year.
Strategic Financial Flexibility: UHS expanded its credit facilities by $900 million to support acquisitions, including Talkspace, and to prioritize shareholder returns through buybacks and dividends.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Seasonal Volume Trends: The company faced challenges due to more dynamic seasonal volume trends, which impacted first-quarter performance.
Winter Weather Impact: Acute care volumes were negatively affected by winter weather in certain markets, leading to a 200 basis point impact.
Health Insurance Exchange Trends: Declines in health insurance exchange adjusted admissions and concerns over premium payment sustainability are expected to have a $75 million pre-tax impact for the year.
California Nurse Staffing Ratio Requirements: The company is working to meet California's nurse staffing ratio requirements by June 1, which could pose operational challenges.
Behavioral Health Volume Growth: Behavioral health volume growth was impacted by winter weather, reducing growth by approximately 40 to 50 basis points.
Labor Costs in Behavioral Health Segment: Salaries, wages, and benefits in the behavioral health segment increased by approximately 6%, which could pressure margins.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Talkspace Acquisition: The acquisition of Talkspace, a virtual outpatient behavioral health care platform, is expected to accelerate the company's ability to create an end-to-end continuum of behavioral health care services. The deal is projected to be accretive to earnings within the first 12 months post-closing and increasingly accretive thereafter. By year 3 post-closing, the effective EBITDA multiple for the transaction is expected to be in the single-digit range.
AI and Technology Initiatives: In 2026, the company is focusing on deploying AI solutions in clinical operations to improve hospital-level efficiency and patient experience. These initiatives are expected to incrementally improve margins over time and enhance quality and patient experience.
Revenue Growth: The company expects same-facility revenue growth to balance between volume and pricing as the year progresses, with first-quarter volume performance impacted by seasonal factors.
Behavioral Health Segment: The company plans to open a 120-bed de novo hospital in Missouri later in 2026 and is making progress on California's nurse staffing ratio requirements, which are expected to be met by June 1, 2026.
Acute Care Segment: Investments include a 156-bed de novo hospital in Florida scheduled to open in May 2026 and two bed towers and a replacement hospital project comprising 178 beds, expected to go online in the second quarter of 2026.
Capital Allocation: The company plans to remain active with share repurchases throughout 2026 and has expanded its credit facilities by $900 million to support acquisitions, including the Talkspace transaction, and other capital allocation priorities.
2026 Financial Outlook: The company is reiterating its financial and operating forecasts for 2026, with plans to reevaluate annual guidance in conjunction with second-quarter earnings in July.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividends: The company has prioritized returning capital to shareholders through dividends, as mentioned in the context of their balance sheet and capital allocation strategy.
Share Buyback Program: During the first quarter of 2026, the company repurchased 675,000 shares at a total cost of $127 million. As of March 31, 2026, there was $1.3 billion of repurchase authorization available under the stock buyback program. The company plans to remain active with share repurchases throughout 2026, including before and after the closing of the Talkspace acquisition.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What was the core growth on an EBITDA basis in the acute side?
A:Steve Filton stated that it was in the low single-digit range.
Q:Can you provide examples of meaningful AI use cases being deployed?
A:Marc Miller mentioned that they have deployed and scaled 8 different AI solutions into revenue cycle operations, resulting in benefits like increased efficiency, financial improvements, better denials management, and increased revenue. They are also focusing on administrative functions and clinical operations to improve patient experience and outcomes.
Q:Is the $120 million to $130 million year-over-year benefit from total Medicaid supplemental payments accurate?
A:Steve Filton confirmed that it is accurate and noted that the $46 million of out-of-period DPP in Q1 aligns with their guidance. He also mentioned that the ramp in earnings for the rest of the year is expected to meet the 5% growth expectation.
Q:What are the drivers of growth in behavioral volumes excluding weather impacts?
A:Steve Filton highlighted two trends: increased staffing in behavioral facilities to meet patient demand and a focus on outpatient growth, which is capturing more demand as it shifts to outpatient settings.
Q:How are bad debt reserve trends performing given Medicaid disenrollment and ACA subsidy expiration?
A:Steve Filton noted a decline in HICS volume in Q1 and recorded an additional reserve for patients who may lose coverage due to non-payment of premiums. He stated that the $75 million negative estimate for the year remains valid and that payer mix changes were minor.
Q:What drove stronger pricing in the quarter, and why is moderation expected for the rest of the year?
A:Steve Filton attributed stronger pricing to higher acuity patients due to a lower flu component and healthy increases in acute service lines like cardiology, orthopedics, and neurology. Moderation is expected as these factors normalize.
Q:What is being done to control professional fees, particularly in radiology?
A:Steve Filton mentioned competitive RFPs, reducing locum physicians, and daily management efforts to keep professional fees within single-digit inflationary rates.
Q:What changes were observed in payer mix during the quarter?
A:Steve Filton reported a slight decline in Medicaid utilization, a slight increase in uninsured volumes, and a slight increase in Medicare volumes.
Q:What is the status of Florida and California Medicaid supplemental payment programs?
A:Steve Filton expressed confidence in the approval of Florida's 2025 program, estimating a $50 million benefit that could be higher. For California, he noted uncertainty and no current estimates for potential benefits.
Q:What is the outlook for core growth excluding DPP and other nonrecurring items?
A:Steve Filton acknowledged that core growth excluding DPP and other nonrecurring items was not at the 5% target in Q1 but expressed confidence in achieving it for the full year.
Q:What are the trends in HICS volumes and expectations for the year?
A:Steve Filton noted a 5% decline in HICS volumes in Q1 and expects the decline to reach 25%-30% for the year, consistent with their estimates.
Q:How did volumes progress throughout the quarter, including March and April?
A:Steve Filton stated that flu and weather impacts were more significant in January and February, with March showing more normalized volumes.
Q:What is the outlook for Medicaid volumes for the year?
A:Steve Filton expects slight declines in Medicaid utilization, consistent with Q1 trends, and no major changes in payer mix outside of HICS.
Q:What is the update on de novo hospitals and their expected EBITDA performance?
A:Steve Filton stated that the new hospital in Florida is expected to incur an operating loss for the year, offset by gains at Cedar Hill in D.C. He also mentioned positive growth impacts from new capacity in existing markets.
Q:Are there increasing levels of denials, and how are they being managed?
A:Steve Filton stated that there are no significant increases in denials and credited investments in revenue cycle technology and processes for maintaining efficiency.
Q:What is the demand versus supply equilibrium in behavioral health?
A:Steve Filton noted strong demand for behavioral health services, with challenges in staffing being addressed. He also mentioned a shift in demand towards outpatient settings.
Q:How is the outpatient behavioral health strategy influencing capital allocation?
A:Steve Filton emphasized continued investments in outpatient behavioral health, including the Talkspace acquisition, while maintaining active share repurchase programs.
Q:What are the trends in turnover rates for behavioral health staff?
A:Steve Filton reported progress in reducing turnover rates, which remain high but are improving due to investments in staffing and retention efforts.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the exact core EBITDA growth calculation for the hospital business excluding DPP and other nonrecurring items, citing difficulty in precise calculations. Additionally, they did not provide a clear timeline for the approval of Florida and California Medicaid supplemental payment programs or specific updates on payer behavior trends by client.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI governance
AI solution
CEO Miller
Filton detail
Filton remark
IOPs ability
Investor Relations
Lehrich Vice
Miller Chief
Miller remark
President Investor
Services Conference
access
acquisition
addition
care patient
clinician
continuum
domain
efficiency
end
health care
industry
level care
location
measure
net NCI
offering
opportunity
outpatient service
platform
quality experience
risk factor
technology
transaction
use case
UHS Transcript
Universal Health Services, Inc. (UHS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-9
Universal Health Services, Inc. (UHS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-12
Universal Health Services, Inc. (UHS) Q1 2026 Earnings Call Transcript
Unknown4-28
The earnings call summary provides mixed signals. While there are positive aspects such as revenue growth and operational improvements, there are also concerns about adverse impacts from health insurance exchanges, staffing regulations, and the expected operating loss for a new hospital. The Q&A session highlights uncertainties in Medicaid payments and payer mix changes, but also notes positive trends in behavioral health demand and outpatient growth. Overall, the balance of positive and negative factors suggests a neutral stock price movement over the next two weeks.
Universal Health Services, Inc. (UHS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
UHS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
